









市场行情
/
股票
/
nasdaq-dvax
/

Dynavax Technologies Corp

DVAX

15.380USD

+4.250+38.19%

收盘 12/24, 13:00（美东）报价延迟15分钟

1.81B总市值

亏损市盈率 TTM



Dynavax Technologies Corp

15.380

+4.250+38.19%

概览公司财务分析

概览

公司

财务

分析

关于 Dynavax Technologies Corp 公司

Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company developing and commercializing vaccines to help protect against infectious diseases. The Company has two commercial products: HEPLISAV-B vaccine (Hepatitis B Vaccine (Recombinant), Adjuvanted), and CpG 1018 adjuvant. The HEPLISAV-B vaccine is used for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose in-one-month adult hepatitis B vaccine. CpG 1018 adjuvant is used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. The Company is advancing a pipeline of differentiated product candidates that leverage its CpG 1018 adjuvant to develop improved vaccines in indications with unmet medical needs. Its pipeline programs include Shingles vaccine program (Z-1018) and Plague vaccine program. Z-1018 is an investigational vaccine candidate being developed for the prevention of shingles in adults aged 50 and older.

Dynavax Technologies Corp简介



公司代码DVAX

公司名称Dynavax Technologies Corp

上市日期Feb 19, 2004

CEOSpencer (Ryan)

员工数量405

证券类型Ordinary Share

年结日Feb 19

公司地址2100 Powell Street

城市EMERYVILLE

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编94608

电话15108485100

网址https://www.dynavax.com/

公司代码DVAX

上市日期Feb 19, 2004

CEOSpencer (Ryan)

Dynavax Technologies Corp公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Ryan Spencer

Chief Executive Officer, Director

277.67K

Dr. Robert (Rob) Janssen, M.D.

Chief Medical Officer, Senior Vice President - Clinical Development, Medical and Regulatory Affairs

74.92K

Mr. David F. Novack

Chief Operating Officer, Senior Vice President

56.05K

+33.36%

Mr. John L. Slebir

Senior Vice President, General Counsel

31.42K

Ms. Elaine D. Sun

Independent Director

29.86K

+23.89%

Ms. Kelly MacDonald, CPA

Chief Financial Officer, Senior Vice President

25.52K

Dr. Peter R. Paradiso, Ph.D.

Independent Director

24.83K

+30.19%

Dr. Daniel L. (Dan) Kisner, M.D.

Independent Director

23.33K

+32.77%

Mr. Brent MacGregor

Independent Director

21.83K

+35.83%

Dr. Emilio Emini

Independent Director

1.44K

名称

名称/职务

职务

持股

持股变动

Mr. Ryan Spencer

Chief Executive Officer, Director

277.67K

Dr. Robert (Rob) Janssen, M.D.

Chief Medical Officer, Senior Vice President - Clinical Development, Medical and Regulatory Affairs

74.92K

Mr. David F. Novack

Chief Operating Officer, Senior Vice President

56.05K

+33.36%

Mr. John L. Slebir

Senior Vice President, General Counsel

31.42K

Ms. Elaine D. Sun

Independent Director

29.86K

+23.89%

Ms. Kelly MacDonald, CPA

Chief Financial Officer, Senior Vice President

25.52K

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

业务USD

名称

营收

占比

HEPLISAV-B

91.87M

96.26%

Other revenue

3.57M

3.74%

地区USD

名称

营收

占比

93.57M

98.04%

Non-US

1.88M

1.96%

业务

地区

业务USD

名称

营收

占比

HEPLISAV-B

91.87M

96.26%

Other revenue

3.57M

3.74%

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

Deep Track Capital LP

13.39%

BlackRock Institutional Trust Company, N.A.

12.52%

The Vanguard Group, Inc.

6.88%

State Street Investment Management (US)

5.35%

Millennium Management LLC

3.86%

其他

58.00%

持股股东

占比

Deep Track Capital LP

13.39%

BlackRock Institutional Trust Company, N.A.

12.52%

The Vanguard Group, Inc.

6.88%

State Street Investment Management (US)

5.35%

Millennium Management LLC

3.86%

其他

58.00%

股东类型

持股股东

占比

Investment Advisor

36.25%

Hedge Fund

33.74%

Investment Advisor/Hedge Fund

21.02%

Research Firm

6.07%

Pension Fund

1.18%

Individual Investor

0.60%

Bank and Trust

0.40%

Private Equity

0.04%

Sovereign Wealth Fund

0.03%

其他

0.67%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

546

115.83M

109.38%

+66.95K

2025Q3

565

115.78M

113.44%

+813.17K

2025Q2

563

116.95M

120.36%

-13.51M

2025Q1

558

131.20M

118.77%

-16.39M

2024Q4

550

133.28M

116.08%

-4.50M

2024Q3

545

132.56M

115.53%

-2.40M

2024Q2

531

134.71M

114.10%

-1.03M

2024Q1

527

135.87M

107.19%

-4.14M

2023Q4

514

128.04M

106.45%

-253.89K

2023Q3

500

128.23M

106.72%

-886.82K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Deep Track Capital LP

15.73M

13.41%

-2.07M

-11.61%

Aug 22, 2025

BlackRock Institutional Trust Company, N.A.

15.80M

13.47%

-2.85M

-15.27%

Jun 30, 2025

The Vanguard Group, Inc.

8.40M

7.17%

-266.13K

-3.07%

Jun 30, 2025

State Street Investment Management (US)

6.40M

5.45%

-394.51K

-5.81%

Jun 30, 2025

Millennium Management LLC

1.61M

1.38%

+1.39M

+612.12%

Jun 30, 2025

Chicago Capital, LLC

5.23M

4.46%

-116.66K

-2.18%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

3.64M

3.11%

-365.20K

-9.11%

Jun 30, 2025

Renaissance Technologies LLC

2.89M

2.46%

+181.00K

+6.69%

Jun 30, 2025

Two Sigma Investments, LP

3.80M

3.24%

+1.53M

+67.74%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.69M

2.29%

-377.05K

-12.30%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

Invesco Biotechnology & Genome ETF

2.91%

Virtus LifeSci Biotech Products ETF

1.58%

ETC 6 Meridian Small Cap Equity ETF

1.21%

Invesco S&P SmallCap Health Care ETF

0.62%

ETC 6 Meridian Low Beta Equity Strategy ETF

0.46%

Pacer US Small Cap Cash Cows Growth Leaders ETF

0.42%

State Street SPDR S&P Biotech ETF

0.41%

Themes US Small Cap Cash Flow Champions ETF

0.35%

Royce Quant Small-Cap Quality Value ETF

0.29%

Direxion Daily S&P Biotech Bull 3X Shares

0.25%

Invesco Biotechnology & Genome ETF

占比2.91%

Virtus LifeSci Biotech Products ETF

占比1.58%

ETC 6 Meridian Small Cap Equity ETF

占比1.21%

Invesco S&P SmallCap Health Care ETF

占比0.62%

ETC 6 Meridian Low Beta Equity Strategy ETF

占比0.46%

Pacer US Small Cap Cash Cows Growth Leaders ETF

占比0.42%

State Street SPDR S&P Biotech ETF

占比0.41%

Themes US Small Cap Cash Flow Champions ETF

占比0.35%

Royce Quant Small-Cap Quality Value ETF

占比0.29%

Direxion Daily S&P Biotech Bull 3X Shares

占比0.25%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Dynavax Technologies Corp的前五大股东是谁？



Dynavax Technologies Corp 的前五大股东如下：
Deep Track Capital LP持有股份：15.73M，占总股份比例：13.41%。
BlackRock Institutional Trust Company, N.A.持有股份：15.80M，占总股份比例：13.47%。
The Vanguard Group, Inc.持有股份：8.40M，占总股份比例：7.17%。
State Street Investment Management (US)持有股份：6.40M，占总股份比例：5.45%。
Millennium Management LLC持有股份：1.61M，占总股份比例：1.38%。